Applied Genetic Technologies Corporation (AGTC)
AGTCPrice: $0.39
Fair Value: 🔒
🔒score
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-l... more
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transform... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Susan Washer |
| IPO Date | 2014-03-27 | CAGR | -0.11% |
| Employees | 102 | Website | agtc.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AGTC chart loading...
Fundamentals
Technicals
| Enterprise Value | $-1.86M | P/E Ratio | -0.27 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 0.6 |
| P/CF Ratio | -0.27 | P/FCF Ratio | — |
| EPS | $-1.46 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -35% | Gross Margin | 1% |
| Operating Margin | -203.9% | Profit Margin | -219.77% |
| ROE | -1.24% | ROA | -1.07% |
| ROCE | -1.6% | Current Ratio | 1.97 |
| Quick Ratio | 1.97 | Cash Ratio | 1.84 |
| Debt/Equity | 0.76 | Interest Coverage | -24.78 |
| Altman Z Score | — | Piotroski Score | — |
View Applied Genetic Technologies Corporation financial charts →